Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma.

MLA

Yokose, Takahiro, et al. “Usefulness of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Predicting the Prognosis and Treatment Response of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma.” Cancer Medicine, vol. 9, no. 12, June 2020, pp. 4059–68. EBSCOhost, https://doi.org/10.1002/cam4.3044.

APA

Yokose, T., Kitago, M., Matsusaka, Y., Masugi, Y., Shinoda, M., Yagi, H., Abe, Y., Oshima, G., Hori, S., Endo, Y., Toyama, K., Iwabuchi, Y., Takemura, R., Ishii, R., Nakahara, T., Okuda, S., Jinzaki, M., & Kitagawa, Y. (2020). Usefulness of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma. Cancer Medicine, 9(12), 4059–4068. https://doi.org/10.1002/cam4.3044

Chicago

Yokose, Takahiro, Minoru Kitago, Yohji Matsusaka, Yohei Masugi, Masahiro Shinoda, Hiroshi Yagi, Yuta Abe, et al. 2020. “Usefulness of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Predicting the Prognosis and Treatment Response of Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma.” Cancer Medicine 9 (12): 4059–68. doi:10.1002/cam4.3044.